Blood Purification
Original Paper
Factors Associated with Functional Performance among Patients on Hemodialysis in TaiwanLai Y.-C.a · Wang C.-Y.a · Moi S.-H.b · Wu C.-H.a · Yang C.-H.b · Chen J.-B.aaDivision of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan
bDepartment of Electronic Engineering, National Kaohsiung University of Applied Sciences, Kaohsiung, Taiwan |
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: October 04, 2017
Accepted: December 11, 2017
Published online: April 12, 2018
Issue release date: May 2018
Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 3
ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)
For additional information: https://www.karger.com/BPU
Abstract
Background/Aims: We investigated factors associated with functional performance in hemodialysis (HD) patients as well as their relationships with mortality. Methods: We enrolled 790 HD patients who were followed up from 2009 to 2013. Functional performance was evaluated by Karnofsky Performance Status Scale (KPSS) scores. We examined the associations of clinical variables and all-cause mortality with KPSS scores. Results: Of the participants, 460 had high KPSS scores (range 90–100) and 330 had low KPSS scores (below 80). On multivariate analysis, age and weekly HD sessions were associated with significantly increased odds of a lower KPSS score (age: OR 1.05, 95% CI 1.04–1.07, p < 0.001; weekly HD: OR 2.10, 95% CI 1.37–3.21, p = 0.001). A low KPSS score was a significant predictor of increased all-cause mortality (hazard ratio 1.49; 95% CI 1.02–2.16, p = 0.037), as determined using Cox regression analysis. Conclusion: Functional performance was associated with clinical variables and all-cause mortality in HD patients.
© 2018 S. Karger AG, Basel
Related Articles:
References
-
Daugirdas JT: The post: pre-dialysis plasma urea nitrogen ratio to estimate Kt/V and NPCR: mathematical modeling. Int J Artif Organs 1989; 12: 411–419.
-
Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329: 1001–1006.
-
Merkus MP, Jager KJ, Dekker FW, De Haan RJ, Boeschoten EW, Krediet RT: Quality of life over time in dialysis: the Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int 1999; 56: 720–728.
-
Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 2001; 12: 2797–2806.
-
Chow FY, Briganti EM, Kerr PG, Chadban SJ, Zimmet PZ, Atkins RC: Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Dis 2003; 41: 596–604.
-
Chen JB, Lam KK, Su YJ, Lee WC, Cheng BC, Kuo CC, Wu CH, Lin E, Wang YC, Chen TC, Liao SC: Relationship between Kt/V urea-based dialysis adequacy and nutritional status and their effect on the components of the quality of life in incident peritoneal dialysis patients. BMC Nephrol 2012; 13: 39.
-
Ifudu O, Paul HR, Homel P, Friedman EA: Predictive value of functional status for mortality in patients on maintenance hemodialysis. Am J Nephrol 1998; 18: 109–116.
-
McClellan WM, Anson C, Birkeli K, Tuttle E: Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease. J Clin Epidemiol 1991; 44: 83–89.
-
Mor V, Laliberte L, Morris JN, Wiemann M: The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 1984; 53: 2002–2007.
-
Chamberlain MC, Johnston SK, Glantz MJ: Neoplastic meningitis-related prognostic significance of the Karnofsky performance status. Arch Neurol 2009; 66: 74–78.
-
Hutchinson TA, Boyd NF, Feinstein AR, Gonda A, Hollomby D, Rowat B: Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. J Chronic Dis 1979; 32: 661–666.
-
Arogundade FA, Zayed B, Daba M, Barsoum RS: Correlation between Karnofsky Performance Status Scale and short-form health survey in patients on maintenance hemodialysis. J Natl Med Assoc 2004; 96: 1661–1667.
-
Carlson DM, Johnson WJ, Kjellstrand CM: Functional status of patients with end-stage renal disease. Mayo Clin Proc 1987; 62: 338–344.
-
Ifudu O, Mayers J, Matthew J, Tan CC, Cambridge A, Friedman EA: Dismal rehabilitation in geriatric inner-city hemodialysis patients. JAMA 1994; 271: 29–33.
-
Johansen KL, Dalrymple LS, Delgado C, Kaysen GA, Kornak J, Grimes B, Chertow GM: Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study. J Am Soc Nephrol 2014; 25: 381–389.
-
Johansen KL, Dalrymple LS, Delgado C, Kaysen GA, Kornak J, Grimes B, Chertow GM: Comparison of self-report-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis. Am J Kidney Dis 2014; 64: 600–607.
-
Johansen KL, Dalrymple LS, Delgado C, Chertow GM, Segal MR, Chiang J, Grimes B, Kaysen GA: Factors associated with frailty and its trajectory among patients on hemodialysis. Clin J Am Soc Nephrol 2017; 12: 1100–1108.
-
Shimoda T, Matsuzawa R, Yoneki K, Harada M, Watanabe T, Matsumoto M, Yoshida A, Takeuchi Y, Matsunaga A: Changes in physical activity and risk of all-cause mortality in patients on maintence hemodialysis: a retrospective cohort study. BMC Nephrol 2017; 18: 154.
-
Hotta C, Hiraki K, Wakamiya A, Otobe Y, Watanabe S, Izawa KP, Kaneshiro N, Konno Y, Sakurada T, Shibagaki Y, Kimura K: Relation of physical function and physical activity to sarcopenia in hemodialysis patients: a preliminary study. Int J Cardiol 2015; 191: 198–200.
Article / Publication Details
Received: October 04, 2017
Accepted: December 11, 2017
Published online: April 12, 2018
Issue release date: May 2018
Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 3
ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)
For additional information: https://www.karger.com/BPU
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
